SEOUL, South Korea I May 29, 2025 I Bio-healthcare company Dx&Vx (DXVX) has officially announced the acceleration of its development program for a ...

Here’s what else you need to know to Get Up to Speed and On with Your Day. President Donald Trump’s economic agenda was thrown into chaos on Wednesday after a federal court ruled that he didn’t have ...

Moderna announced positive interim results from an early-stage trial of a vaccine that targeted bird flu virus.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Who doesn't love spending more time in the summer sun? However, it's important to protect your skin and check for signs of ...

A new type of coronavirus vaccine administered nasally has proven effective when tested on animals, researchers at the ...

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed ...

Indeed, this study provides visual evidence that all the components fit together directly like individual machine parts. In doing so, they reveal an important function of the supercomplex: connecting ...

Other parts of the NIH like the National Cancer Institute also fund this work, because mRNA technology holds promise for targeted cancer treatment. "I am on pins and needles constantly," says ...

mRNA technology has shown the potential to deliver ... but they’re souring on other parts of the public health consensus, including long-held recommendations for childhood vaccines.

Personalized mRNA vaccines show promise as pancreatic cancer ... Pancreatic cancer cells also spread to other parts of the body much earlier on than in other cancers, which typically spread ...